학술논문
148O - Phase III evaluating the addition of fulvestrant (F) to anastrozol (A) as adjuvant therapy in postmenopausal women with hormone receptor positive HER2 negative (HR+/HER2-) early breast cancer (EBC): Results from the GEICAM/2006-10 study
Document Type
Abstract
Author
Ruiz-Borrego, M.; Martin Jimenez, M.; Ruiz, A.; Lluch, A.; Ramos, M.; Cruz Jurado, J.; Baena-Canada, J.M.; Cirauqui, B.; Rodriguez-Lescure, A.; Alba Conejo, E.; Martínez Jañez, N.; Muñoz, M.; Antolin, S.; Álvarez López, I.; Del Barco, S.; Garcia-Estevez, L.; Chacon Lopez-Muniz, J.I.; Anton Torres, A.; Carrasco, E.
Source
In Annals of Oncology September 2017 28 Supplement 5:v43-v43
Subject
Language
ISSN
0923-7534